Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study
- PMID: 16399706
- PMCID: PMC1326929
- DOI: 10.1136/bmj.38701.440961.7C
Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study
Abstract
Objective: To assess the effect of introducing testing for human papillomavirus combined with liquid based cytology in women with low grade cytological abnormalities.
Design: Observational before and after study.
Setting: Three cervical screening laboratories, England.
Participants: 5654 women aged 20-64 with low grade cytological abnormalities found at routine cervical screening in a pilot; 5254 similar women in the period before the pilot.
Interventions: Human papillomavirus testing combined with liquid based cytology in the management of women with borderline or mildly dyskaryotic cervical smear results compared with conventional smear tests, with immediate referral to colposcopy of women positive for human papillomavirus.
Results: 57.9% (3187/5506) of women tested in the pilot were positive for human papillomavirus. The rate of repeat smears fell by 74%, but the rate of referral to colposcopy for low grade cytological abnormalities more than doubled. The estimated negative predictive value of human papillomavirus testing varied between 93.8% and 99.7%.
Conclusion: The addition of testing for human papillomavirus in women with low grade cytological abnormalities resulted in a reduction in the rate of repeat smears, but an increase in rates of referral to colposcopy.
Comment in
-
When to test women for human papillomavirus.BMJ. 2006 Jan 14;332(7533):61-2. doi: 10.1136/bmj.332.7533.61. BMJ. 2006. PMID: 16410556 Free PMC article. No abstract available.
-
When to test women for human papillomavirus: testing is possible without increasing colposcopy referral rate.BMJ. 2006 Jan 28;332(7535):237. doi: 10.1136/bmj.332.7535.237. BMJ. 2006. PMID: 16439416 Free PMC article. No abstract available.
References
-
- Cuzick J, Sasieni P, Davies P. A systematic review of the role of human papilloma virus testing (HPV) in the cervical screening programme. Health Technol Assess 1999; 1-196. - PubMed
-
- Rana DN, Marshall J, Desai M, et al. Five-year follow-up of women with borderline and mildly dyskaryotic cervical smears. Cytopathology 2004;15: 263-70. - PubMed
-
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. In: IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC Science Publications, 1995.
-
- Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362: 1871-6. - PubMed
-
- Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL triage study (ALTS). Arch Pathol Lab Med 2003;127: 946-9. - PubMed